Lung Cancer Combination Treatment: Evaluation of the Synergistic Effect of Cisplatin Prodrug, Vinorelbine and Retinoic Acid When Co-Encapsulated in a Multi-Layered Nano-Platform

References

• GLOBOCAN. 2018 Available from: http://gco.iarc.fr/. accessed on 124 2019.
   Google Scholar
• SiegelRL, MillerKD, JemalA. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34. doi:10.3322/caac.2155130620402
   PubMed Web of Science ®Google Scholar
• NooneAM, HowladerN, KrapchoM, et al. SEER Cancer Statistics Review, 1975-2015, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2015/., 11 2017 SEER data submission, posted to the SEER web site, April 2018.
   Google Scholar
• GarbuzenkoOB, KuzmovA, TaratulaO, PineSR, MinkoT. Strategy to enhance lung cancer treatment by five essential elements: inhalation delivery, nanotechnology, tumor-receptor targeting, chemo- and gene therapy. Theranostics. 2019;9(26):8362–8376.31754402
   PubMed Web of Science ®Google Scholar
• HowingtonJA, BlumMG, ChangAC, BalekianAA, MurthySC. Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: american College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5Suppl):e278S–e313S.23649443
   PubMed Web of Science ®Google Scholar
• NSCLC Meta-analysis Collaborative Group. Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data. Lancet. 2014;383(9928):1561–1571.24576776
   PubMed Web of Science ®Google Scholar
• MastersGA, TeminS, AzzoliCG, et al. American Society of Clinical Oncology Clinical Practice. Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: american Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2015;33(30):3488–3515.26324367
   PubMed Web of Science ®Google Scholar
• BradburyP, SivajohanathanD, ChanA, KulkarniS, UngY, EllisPM. Postoperative Adjuvant Systemic Therapy in Completely Resected Non-Small-Cell Lung Cancer: A Systematic Review. Clin Lung Cancer. 2017;18(3):259–273.e8.28162945
   PubMed Web of Science ®Google Scholar
• ArriagadaR, BergmanB, DunantA, Le ChevalierT, PignonJP, VansteenkisteJ. International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med. 2004;350(4):351–360.14736927
   PubMed Web of Science ®Google Scholar
• SocinskiMA, EvansT, GettingerS, et al. Treatment of stage IV non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: american College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5):e341S–e368S. doi:10.1378/chest.12-236123649446
   PubMed Web of Science ®Google Scholar
• CampbellAB, KalmanSM, JacobsC. Plasma platinum levels: relationship to cisplatin dose and nephrotoxicity. Cancer Treat Rep. 1983;67(2):169–172.6681731
   PubMedGoogle Scholar
• MatsuiK, MasudaN, UchidaY, et al. Determinants of myelosuppression in the treatment of non-small cell lung cancer with cisplatin-containing chemotherapy. Jpn J Cancer Res. 1996;87(7):781–786. doi:10.1111/j.1349-7006.1996.tb00292.x8698630
   PubMedGoogle Scholar
• LiD, CuiR, XuS, LiuY. Synergism of cisplatin-oleanolic acid co-loaded hybrid nanoparticles on gastric carcinoma cells for enhanced apoptosis and reversed multidrug resistance. Drug Deliv. 2020;27(1):191–199. doi:10.1080/10717544.2019.171062231924110
   PubMed Web of Science ®Google Scholar
• YangC, TuK, GaoH, et al. The novel platinum(IV) prodrug with self-assembly property and structure-transformable character against triple-negative breast cancer. Biomaterials. 2020;232:119751. doi:10.1016/j.biomaterials.2019.11975131918218
   PubMed Web of Science ®Google Scholar
• GuoS, WangY, MiaoL, XuZ, LinC-HM, HuangL. Turning a water and oil insoluble cisplatin derivative into a nanoparticle formulation for cancer therapy. Biomaterials. 2014;35(26):7647–7653. doi:10.1016/j.biomaterials.2014.05.04524920436
   PubMed Web of Science ®Google Scholar
• WangG, WangZ, LiC, et al. RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy. Biomed Pharmacother. 2018;106:275–284. doi:10.1016/j.biopha.2018.06.13729966971
   PubMed Web of Science ®Google Scholar
• Al-AttarT, MadihallySV. Recent advances in the combination delivery of drug for leukemia and other cancers. Expert Opin Drug Deliv. 2020;22:1–11.
   Google Scholar
• GurunathanS, KangMH, QasimM, KimJH. Nanoparticle-Mediated Combination Therapy: two-in-One Approach for Cancer. Int J Mol Sci. 2018;20(10):19.
   PubMedGoogle Scholar
• CostantiniL, MolinariR, FarinonB, MerendinoN. Retinoic Acids in the Treatment of Most Lethal Solid Cancers. J Clin Med. 2020;9(2):28. doi:10.3390/jcm9020360
   Web of Science ®Google Scholar
• ZhangY, ZhaoJ, SunJ, HuangL, LiQ. Targeting lung cancer initiating cells by all-trans retinoic acid-loaded lipid-PLGA nanoparticles with CD133 aptamers. Exp Ther Med. 2018;16(6):4639–4649.30542415
   PubMed Web of Science ®Google Scholar
• Di MasiA, LeboffeL, DeME, PaganoF, CicconiL. Retinoic acid receptors: from molecular mechanisms to cancer therapy. Mol Aspects Med. 2015;41:1–115.25543955
   PubMed Web of Science ®Google Scholar
• Quintero BarceinasRS, García-RegaladoA, Aréchaga-OcampoE, Villegas-SepúlvedaN. All-Trans Retinoic Acid Induces Proliferation, Survival, and Migration in A549 Lung Cancer Cells by Activating the ERK Signaling Pathway through a Transcription-Independent Mechanism. Biomed Res Int. 2015;2015:404368.26557664
   PubMed Web of Science ®Google Scholar
• YucelC, Erdogan YucelE, ArslanFD, et al. All-trans retinoic acid prevents cisplatin-induced nephrotoxicity in rats. Naunyn Schmiedebergs Arch Pharmacol. 2019;392(2):159–164.30610249
   PubMed Web of Science ®Google Scholar
• ZhuYH, YeN, TangXF, et al. Synergistic Effect of Retinoic Acid Polymeric Micelles and Prodrug for the Pharmacodynamic Evaluation of Tumor Suppression. Front Pharmacol. 2019;10:447.31156425
   PubMed Web of Science ®Google Scholar
• PeerD, KarpJM, HongS, FarokhzadOC, MargalitR, LangerR. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2(12):751–760.18654426
   PubMed Web of Science ®Google Scholar
• SuhMS, ShenJ, KuhnLT, BurgessDJ. Layer-by-layer nanoparticle platform for cancer active targeting. Int J Pharm. 2017;517(1–2):58–66.27923697
   PubMed Web of Science ®Google Scholar
• HuangWT, LarssonM, LeeYC, LiuDM, ChiouGY. Dual drug-loaded biofunctionalized amphiphilic chitosan nanoparticles: enhanced synergy between cisplatin and demethoxycurcumin against multidrug-resistant stem-like lung cancer cells. Eur J Pharm Biopharm. 2016;109:165–173.27793756
   PubMed Web of Science ®Google Scholar
• VergaraD, BellomoC, ZhangX, et al. Lapatinib/Paclitaxel polyelectrolyte nanocapsules for overcoming multidrug resistance in ovarian cancer. Nanomedicine. 2012;8(6):891–899.
   PubMed Web of Science ®Google Scholar
• ZhouD, XiaoH, MengF, et al. Layer-by-layer assembled polypeptide capsules for platinum-based pro-drug delivery. Bioconjug Chem. 2012;23(12):2335–2343.23176570
   PubMed Web of Science ®Google Scholar
• TanS, WangG. Lung cancer targeted therapy: folate and transferrin dual targeted, glutathione responsive nanocarriers for the delivery of cisplatin. Biomed Pharmacother. 2018;102:55–63.29549729
   PubMed Web of Science ®Google Scholar
• YuW, LiuC, LiuY, ZhangN, XuW. Mannan-modified solid lipid nanoparticles for targeted gene delivery to alveolar macrophages. Pharm Res. 2010;27(8):1584–1596.20422265
   PubMed Web of Science ®Google Scholar
• RamasamyT, TranTH, ChoiJY, et al. Layer-by-layer coated lipid-polymer hybrid nanoparticles designed for use in anticancer drug delivery. Carbohydr Polym. 2014;102:653–661.24507332
   PubMed Web of Science ®Google Scholar
• ZhangR, RuY, GaoY, LiJ, MaoS. Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer. Drug Des Devel Ther. 2017;11:2631–2642.
   PubMed Web of Science ®Google Scholar
• YueY, ZhaoD, YinQ. Hyaluronic acid modified nanostructured lipid carriers for transdermal bupivacaine delivery: in vitro and in vivo anesthesia evaluation. Biomed Pharmacother. 2018;98:813–820.29571251
   PubMed Web of Science ®Google Scholar
• ArantesVT, FaracoAAG, FerreiraFB, et al. Retinoic acid-loaded solid lipid nanoparticles surrounded by chitosan film support diabetic wound healing in in vivo study. Colloids Surf B Biointerfaces. 2019;188:110749.31927466
   PubMed Web of Science ®Google Scholar
• GongZ, ChenM, RenQ, YueX, DaiZ. Fibronectin-targeted dual-acting micelles for combination therapy of metastatic breast cancer. Signal Transduct Target Ther. 2020;5:12.32296050
   PubMed Web of Science ®Google Scholar
• LiS, WangL, LiN, LiuY, SuH. Combination lung cancer chemotherapy: design of a pH-sensitive transferrin-PEG-Hz-lipid conjugate for the co-delivery of docetaxel and baicalin. Biomed Pharmacother. 2017;95:548–555.28869892
   PubMed Web of Science ®Google Scholar
• TanS, WangG. Redox-responsive and pH-sensitive nanoparticles enhanced stability and anticancer ability of erlotinib to treat lung cancer in vivo. Drug Des Devel Ther. 2017;11:3519–3529.
   PubMed Web of Science ®Google Scholar
• ZhangY, ZhangP, ZhuT. Ovarian carcinoma biological nanotherapy: comparison of the advantages and drawbacks of lipid, polymeric, and hybrid nanoparticles for cisplatin delivery. Biomed Pharmacother. 2019;109:475–483.30399584
   PubMed Web of Science ®Google Scholar
• ShaoY, LuoW, GuoQ, LiX, ZhangQ, LiJ. In vitro and in vivo effect of hyaluronic acid modified, doxorubicin and gallic acid co-delivered lipid-polymeric hybrid nano-system for leukemia therapy. Drug Des Devel Ther. 2019;13:2043–2055.
   PubMed Web of Science ®Google Scholar
• ZhuQY, ScarboroughA, PolskyB, ChouTC. Drug combinations and effect parameters of zidovudine, stavudine, and nevirapine in standardized drug-sensitive and resistant HIV type 1 strains. AIDS Res Hum Retroviruses. 1996;12(6):507–517.8679306
   PubMed Web of Science ®Google Scholar
• ChouTC. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 2010;70(2):440–446.20068163
   PubMed Web of Science ®Google Scholar
• WangH, SunG, ZhangZ, OuY. Transcription activator, hyaluronic acid and tocopheryl succinate multi-functionalized novel lipid carriers encapsulating etoposide for lymphoma therapy. Biomed Pharmacother. 2017;91:241–250.28460227
   PubMed Web of Science ®Google Scholar
• ZhangY, YangC, WangW, et al. Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer. Sci Rep. 2016;6:21225.26876480
   PubMed Web of Science ®Google Scholar
• YangF, LiA, LiuH, ZhangH. Gastric cancer combination therapy: synthesis of a hyaluronic acid and cisplatin containing lipid prodrug coloaded with sorafenib in a nanoparticulate system to exhibit enhanced anticancer efficacy and reduced toxicity. Drug Des Devel Ther. 2018;12:3321–3333.
   PubMed Web of Science ®Google Scholar
• LazarevićT, RilakA, BugarčićŽD. Platinum, palladium, gold and ruthenium complexes as anticancer agents: current clinical uses, cytotoxicity studies and future perspectives. Eur J Med Chem. 2017;142:8–31.28442170
   PubMed Web of Science ®Google Scholar
• Ling X, Tu J, Wang J, Shajii A, Kong N, Feng C, Zhang Y, Yu M, Xie T, Bharwani Z, Aljaeid BM, Shi B, Tao W, Farokhzad OC. Glutathione-Responsive Prodrug Nanoparticles for Effective Drug Delivery and Cancer Therapy. ACS Nano. 2019;13(1):357–370.30485068
   PubMed Web of Science ®Google Scholar
• SituAJ, KangSM, FreyBB, AnW, KimC, UlmerTS. Membrane Anchoring of α-Helical Proteins: role of Tryptophan. J Phys Chem B. 2018;122(3):1185–1194.29323921
   PubMed Web of Science ®Google Scholar
• SadokI, GamianA, StaniszewskaMM. Chromatographic analysis of tryptophan metabolites. J Sep Sci. 2017;40(15):3020–3045.28590049
   PubMed Web of Science ®Google Scholar
• DuanW, LiuY. Targeted and synergistic therapy for hepatocellular carcinoma: monosaccharide modified lipid nanoparticles for the co-delivery of doxorubicin and sorafenib. Drug Des Devel Ther. 2018;12:2149–2161.
   PubMed Web of Science ®Google Scholar
• LeeY, LeeH, KimYB, et al. Bioinspired Surface Immobilization of Hyaluronic Acid on Monodisperse Magnetite Nanocrystals for Targeted Cancer Imaging. Adv Mater. 2008;20(21):4154–4157.19606262
   PubMed Web of Science ®Google Scholar
• CultyM, ShizariM, ThompsonEW, UnderhillCB. Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: correlation with invasive potential. J Cell Physiol. 1994;160(2):275–286.7518822
   PubMed Web of Science ®Google Scholar
• ZhangG, LiuF, JiaE, JiaL, ZhangY. Folate-modified, cisplatin-loaded lipid carriers for cervical cancer chemotherapy. Drug Deliv. 2016;23(4):1393–1397.26165422
   PubMed Web of Science ®Google Scholar
• JeonS, YooCY, ParkSN. Improved stability and skin permeability of sodium hyaluronate-chitosan multilayered liposomes by Layer-by-Layer electrostatic deposition for quercetin delivery. Colloids Surf B Biointerfaces. 2015;129:7–14.25819360
   PubMed Web of Science ®Google Scholar
• ZhangC, PanD, LiJ, et al. Enzyme-responsive peptide dendrimer-gemcitabine conjugate as a controlled-release drug delivery vehicle with enhanced antitumor efficacy. Acta Biomater. 2017;55:153–162.28259838
   PubMed Web of Science ®Google Scholar
• KimM, KimYS, KimKM, et al. Combination of Sasa quelpaertensis Nakai leaf extract and cisplatin suppresses the cancer stemness and invasion of human lung cancer cells. Integr Cancer Ther. 2014;13(6):529–540.24838270
   PubMed Web of Science ®Google Scholar
• TranTH, ChoiJY, RamasamyT, et al. Hyaluronic acid-coated solid lipid nanoparticles for targeted delivery of vorinostat to CD44 overexpressing cancer cells. Carbohydr Polym. 2014;114:407–415.25263908
   PubMed Web of Science ®Google Scholar
• LuZ, SuJ, LiZ, ZhanY, YeD. Hyaluronic acid-coated, prodrug-based nanostructured lipid carriers for enhanced pancreatic cancer therapy. Drug Dev Ind Pharm. 2017;43(1):160–170.27553814
   PubMed Web of Science ®Google Scholar
• YuanYG, GurunathanS. Combination of graphene oxide-silver nanoparticle nanocomposites and cisplatin enhances apoptosis and autophagy in human cervical cancer cells. Int J Nanomedicine. 2017;12:6537–6558.28919753
   PubMed Web of Science ®Google Scholar
• ChengY, ZhaoP, WuS, et al. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma. Int J Pharm. 2018;545(1–2):261–273.29730175
   PubMed Web of Science ®Google Scholar
• LiC, GeX, WangL. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: a synergistic combination nanotherapy for cervical cancer. Biomed Pharmacother. 2017;86:628–636.28027539
   PubMed Web of Science ®Google Scholar
• LiaoH, ZhaoS, WangH, LiuY, ZhangY, Self-AssemblySG. Of Retinoid Nanoparticles For Melanoma Therapy. Int J Nanomedicine. 2019;14:7963–7973.31632011
   PubMed Web of Science ®Google Scholar
• Xie F, Ding RL, He WF, Liu ZJ, Fu SZ, Wu JB, Yang LL, Lin S, Wen QL. In vivo antitumor effect of endostatin-loaded chitosan nanoparticles combined with paclitaxel on Lewis lung carcinoma. Drug Deliv. 2017;24(1):1410–1418.28933203
   PubMed Web of Science ®Google Scholar
• LiuL, DaiH, WuY, et al. In vitro and in vivo mechanism of hepatocellular carcinoma inhibition by β-TCP nanoparticles. Int J Nanomedicine. 2019;14:3491–3502.31190806
   PubMed Web of Science ®Google Scholar
• LiuJ, ZhangD, LianS, et al. Redox-responsive hyaluronic acid-functionalized graphene oxide nanosheets for targeted delivery of water-insoluble cancer drugs. Int J Nanomedicine. 2018;13:7457–7472.30532533
   PubMed Web of Science ®Google Scholar